Zydus Lifesciences
Zydus Lifesciences Q4 net profit surges 4-fold to Rs 1,182 cr; revenue at Rs 5,534 cr
Zydus Lifesciences gets USFDA nod to market generic arthritis drug in US
Zydus Lifesciences' new drug application for Desidustat accepted in China
Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients
Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical